… During the past decade and a half, we have witnessed the appearance of a significant
number of new agents for the treatment of osteoporosis. With the exception of teriparatide, all the …

… Osteoporosis is a disorder … Osteoporosis affects both women and men although women
are at greatest risk [3]. With life expectancy of the world’s population increasing, osteoporosis …

… for clinicians and researchers with an interest in osteoporosis. This update will focus on the
… explore recent evidence that suggests that osteoporosis medications may be linked to an …

… To review new discoveries that revisit our current thinking on the genesis of osteoporosis …
medical conditions, postmenopausal osteoporosis and hyperthyroid osteoporosis, and in doing …

… osteoporosis, and, successively, there is, obviously, a room for improvement in the approach
toward stratification and management of people at risk of osteoporosis … of osteoporosis and …

… process of bone and the pathogenesis of osteoporosis, research on the mechanisms of age-…
management of osteoporosis in the older adults including traditional osteoporosis therapy …

… ’ in treatment of osteoporosis. Therefore, it seems paradoxical that the majority of new
osteoporosis therapies on the horizon also target the osteoclast. Several of these new agents are …

… therapies for osteoporosis that have recently been introduced or that are in development.
Newly discovered mechanisms that form the basis for these new developments are focused on. …

… The scope of this article is to discuss the incorporation of recent concepts in osteoporosis,
the development of new interventional thresholds and its implication on strategies for …

… Outside the US, teriparatide is joined only by intact PTH (1–84) as anabolic therapy for
osteoporosis treatment. Although both anabolic and antiresorptive medications improve bone …